Procter & Gamble Co. buy BNP Paribas Exane
Start price
27.09.25
/
50%
€130.46
Target price
27.09.26
€146.97
Performance (%)
-5.11%
Price
10.04.26
€123.80
Summary
This prediction is currently active. With a performance of -5.11%, the BUY prediction by BNP_Paribas_Exane is trending in the wrong direction. This prediction currently runs until 27.09.26. The prediction end date can be changed by BNP_Paribas_Exane at any time. BNP_Paribas_Exane has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Procter & Gamble Co. | -0.226% | -0.226% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by BNP_Paribas_Exane for this prediction
In the thread Procter & Gamble Co. diskutieren
Procter & Gamble (NYSE:PG) had its price target lowered by analysts at BNP Paribas Exane from $177.00 to $172.00. They now have an "outperform" rating on the stock.
Ratings data for PG provided by MarketBeat
Stopped prediction by BNP_Paribas_Exane for Procter & Gamble Co.
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€124.98
18.01.26
18.01.26
€141.30
18.01.27
18.01.27
-0.94%
10.04.26
10.04.26
